6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
Accreditation: 10.00 AMA PRA Category 1 Credit™ | 10.00 ABIM MOC II | 10.00 Nursing Contact Hours | 10.00 ACPE Pharmacy
Venue: Hyatt Regency San Francisco Downtown SOMA, 50 3rd Street, San Francisco, CA, United States
Official conference page for 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy. https://binaytara.org/projects/conferences/6th-binaytara-precision-oncology-summit-at-the-forefront-of-targeted-cancer-therapy
About 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy
Overview
Trusted by Thousands of Attendees
Across Our Events
Faculty and committee
Our Speakers
Faculty
Conference program and agenda
Our Agenda
Day 1: Friday, September 11th, 2026
All timings are in Pacific Time (PDT, GMT-07:00) time.
10:00 AM - 10:30 AM
Target Discovery and Validation – Dennis Slamon, MD, PhD
10:30 AM - 10:45 AM
Overview of germline vs. somatic mutations in cancer predisposition - Role in therapy selection across tumor types – Siddhartha Yadav, MD
10:45 AM - 11:00 AM
Current targeted therapies for germline alterations – Melinda L. Telli, MD
11:00 AM - 11:15 AM
Near-Future Pipeline Agents Targeting Germline DNA alterations in Cancer Medicine
11:15 AM - 11:30 AM
VHL-targeted: Belzutifan for RCC/Pheo
11:30 AM - 11:45 AM
Panel Discussion
11:45 AM - 12:00 PM
NHS-Galleri Trial
12:00 PM - 12:15 PM
Sensitive Detection of MRD in Early-stage Cancer – Milana v Dolezal, MD
12:15 PM - 12:30 PM
Controversies in Treatment-emergent Drug Resistance Mutations: Intervention Prior to RECIST Disease Progression
12:30 PM - 01:00 PM
Panel Discussion
02:00 PM - 02:15 PM
Novel ADC Linker/Payload Considerations
02:15 PM - 02:30 PM
Therapeutic strategies targeting brain metastases
02:30 PM - 03:00 PM
Panel Discussion
Session Chair: James M. Ford, MD
Session Chair: Vivek Subbiah, MD
04:20 PM - 04:35 PM
Adaptive Feedback and Bypass Pathways
04:35 PM - 04:50 PM
Mechanisms of ADC Resistance – Naoto Ueno, MD, PhD, FACP
04:50 PM - 05:05 PM
Tumor Microenvironment Role – Judith A. Varner, PhD
05:05 PM - 05:35 PM
Panel Discussion
Day 2: Saturday, September 12th, 2026